In the present study, we performed a case-control study in a Chinese cohort to test the possible genetic association between RAGE genetic variants and the susceptibility to NSCLC; meanwhile, we also tested the role of RAGE polymorphisms in determining the chemotherapy responses in advanced NSCLC subjects. The gene discussed is AGER; the disease is non-small cell lung carcinoma.